PMID- 30267296
OWN - NLM
STAT- MEDLINE
DCOM- 20190410
LR  - 20190410
IS  - 1573-2606 (Electronic)
IS  - 1389-9155 (Linking)
VI  - 19
IP  - 2
DP  - 2018 Jun
TI  - Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in 
      detecting and localizing pancreatic neuroendocrine tumors?
PG  - 133-137
LID - 10.1007/s11154-018-9464-1 [doi]
AB  - To compare endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI) 
      in terms of their sensitivities to localize pancreatic neuroendocrine tumors 
      (pNET) preoperatively. Systematic analysis of the literature; sensitivity of EUS 
      and MRI in insulinomas and pancreaticoduodenal NETs in multiple endocrine 
      neoplasia type 1 (MEN1) in series of at least 20 subjects referring to tumors 
      confirmed by surgery and histopathology. Other imaging methods reported were also 
      assessed. Eighteen publications on insulinomas (782 cases) could be analyzed, no 
      study in MEN1 fulfilled the inclusion criteria and compared EUS to MRI. Data 
      quality was moderate: all publications referred to case series. Mean correct 
      detection / localization rates (sensitivity) were calculated: EUS 80%, MRI 66%, 
      computed tomography 63%, angiography 52%, somatostatin receptor scintigraphy 42%, 
      ultrasonography 23%; arterial calcium stimulation with hepatic venous sampling 
      regionalized correctly in 80%. EUS seems to be more sensitive than MRI in 
      localizing pancreatic neuroendocrine tumors. If a specialized endosonographist is 
      available, EUS is the preferable imaging procedure. Otherwise, MRI is a suitable 
      alternative.
FAU - Kann, Peter Herbert
AU  - Kann PH
AD  - Centre for Endocrinology, Diabetology & Osteology, Endocrine Laboratory, 
      Philipp's University and University Hospital Marburg, Marburg, Germany. 
      kannp@med.uni-marburg.de.
AD  - German Centre for Endocrine Care, Frankfurt / Main, Germany. 
      kannp@med.uni-marburg.de.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Germany
TA  - Rev Endocr Metab Disord
JT  - Reviews in endocrine & metabolic disorders
JID - 100940588
SB  - IM
MH  - Endosonography/*standards
MH  - Humans
MH  - Magnetic Resonance Imaging/*standards
MH  - Neuroendocrine Tumors/*diagnostic imaging
MH  - Pancreatic Neoplasms/*diagnostic imaging
OTO - NOTNLM
OT  - EUS
OT  - Endoscopic ultrasonography
OT  - Insulinoma
OT  - MRI
OT  - Magnetic resonance imaging
OT  - NET
OT  - Neuroendocrine tumor
EDAT- 2018/09/30 06:00
MHDA- 2019/04/11 06:00
CRDT- 2018/09/30 06:00
PHST- 2018/09/30 06:00 [pubmed]
PHST- 2019/04/11 06:00 [medline]
PHST- 2018/09/30 06:00 [entrez]
AID - 10.1007/s11154-018-9464-1 [pii]
AID - 10.1007/s11154-018-9464-1 [doi]
PST - ppublish
SO  - Rev Endocr Metab Disord. 2018 Jun;19(2):133-137. doi: 10.1007/s11154-018-9464-1.